Macquarie Cuts Surgery Partners (NASDAQ:SGRY) Price Target to $34.00

Surgery Partners (NASDAQ:SGRY) had its price objective cut by Macquarie from $35.00 to $34.00 in a research note published on Wednesday,Benzinga reports. They currently have an outperform rating on the stock.

Other equities research analysts have also issued research reports about the stock. Royal Bank of Canada reissued an “outperform” rating and set a $49.00 price objective on shares of Surgery Partners in a research note on Wednesday, August 7th. StockNews.com downgraded shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, August 7th. Benchmark reiterated a “buy” rating and issued a $50.00 target price on shares of Surgery Partners in a research note on Monday, August 26th. UBS Group assumed coverage on shares of Surgery Partners in a research note on Monday, October 14th. They issued a “buy” rating and a $38.00 target price on the stock. Finally, Citigroup dropped their target price on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a research note on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $40.71.

Surgery Partners Trading Down 7.3 %

NASDAQ:SGRY opened at $22.95 on Wednesday. Surgery Partners has a one year low of $22.25 and a one year high of $36.92. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.69. The company’s 50-day simple moving average is $30.62 and its 200 day simple moving average is $28.43. The firm has a market capitalization of $2.92 billion, a P/E ratio of -47.81, a PEG ratio of 18.74 and a beta of 2.76.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the stock. Janus Henderson Group PLC increased its holdings in Surgery Partners by 7,987.1% during the first quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock valued at $74,701,000 after buying an additional 2,473,282 shares during the last quarter. Deerfield Management Company L.P. Series C increased its holdings in Surgery Partners by 47.7% during the second quarter. Deerfield Management Company L.P. Series C now owns 4,707,287 shares of the company’s stock valued at $111,986,000 after buying an additional 1,520,484 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in Surgery Partners during the second quarter valued at approximately $29,288,000. Victory Capital Management Inc. increased its holdings in Surgery Partners by 140.4% during the third quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock valued at $42,892,000 after buying an additional 777,038 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in Surgery Partners by 26.7% during the second quarter. Dimensional Fund Advisors LP now owns 2,801,091 shares of the company’s stock valued at $66,643,000 after buying an additional 589,499 shares during the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.